{"entities":{"Q40434":{"pageid":30802,"ns":120,"title":"Item:Q40434","lastrevid":129581,"modified":"2026-08-13T06:14:33Z","type":"item","id":"Q40434","labels":{"mul":{"language":"mul","value":"6C4C.71"},"pt-br":{"language":"pt-br","value":"Transtorno de ansiedade induzido por MDMA ou drogas relacionadas"},"en":{"language":"en","value":"MDMA or related drug-induced anxiety disorder"}},"descriptions":{"pt-br":{"language":"pt-br","value":"Transtorno de ansiedade induzido por MDMA ou drogas relacionadas, incluindo MDA \u00e9 caracterizado por sintomas ansiosos (p. ex., apreens\u00e3o ou preocupa\u00e7\u00e3o, medo, sintomas fisiol\u00f3gicos de ativa\u00e7\u00e3o auton\u00f4mica excessiva, comportamento de evita\u00e7\u00e3o) que se desenvolvem durante ou logo ap\u00f3s intoxica\u00e7\u00e3o por MDMA ou drogas relacionadas. A intensidade ou dura\u00e7\u00e3o dos sintomas \u00e9 consideravelmente maior do que sintomas ansiosos caracter\u00edsticos da intoxica\u00e7\u00e3o por MDMA ou drogas relacionadas, incluindo MDA. A quantidade e dura\u00e7\u00e3o do uso de MDMA ou drogas relacionadas devem ser capazes de produzir sintomas de ansiedade. Os sintomas n\u00e3o s\u00e3o mais bem explicados por um transtorno mental prim\u00e1rio (p.ex., transtorno de ansiedade e relacionado ao medo, transtorno depressivo com sintomas ansiosos proeminentes), como pode ser o caso se os sintomas de ansiedade precederam o in\u00edcio do uso de MDMA ou drogas relacionadas, se os sintomas persistem por um per\u00edodo de tempo consider\u00e1vel ap\u00f3s a cessa\u00e7\u00e3o do uso de MDMA ou drogas relacionadas, ou se h\u00e1 outra evid\u00eancia de um transtorno mental prim\u00e1rio preexistente com sintomas ansiosos (p. ex., hist\u00f3ria de epis\u00f3dios anteriores n\u00e3o associados ao uso de MDMA ou drogas relacionadas)."},"en":{"language":"en","value":"MDMA or related drug-induced anxiety disorder, including MDA is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with MDMA or related drugs. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of MDMA or related drug intoxication, including MDA. The amount and duration of MDMA or related drug use must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the MDMA or related drug use, if the symptoms persist for a substantial period of time after cessation of the MDMA or related drug use, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with MDMA or related drug use)."}},"aliases":{},"claims":{"P68":[{"mainsnak":{"snaktype":"value","property":"P68","hash":"3580f59a8a21a367c8aa620a4212f7475d8fda37","datavalue":{"value":"https://id.who.int/icd/entity/325981339","type":"string"},"datatype":"url"},"type":"statement","id":"Q40434$C9ABCA0E-B892-47AB-AC62-BEE242CD40CF","rank":"normal"}],"P67":[{"mainsnak":{"snaktype":"value","property":"P67","hash":"ec087af3fdd83fa1f9419eed52f982b0791cff0a","datavalue":{"value":"CID11:6C4C.71","type":"string"},"datatype":"string"},"type":"statement","id":"Q40434$41240E99-315D-4855-8B36-9EDAB350A4B9","rank":"normal"}],"P70":[{"mainsnak":{"snaktype":"value","property":"P70","hash":"41857fb46f107e10e88c9d18cb717751c3e92809","datavalue":{"value":"dki-india-6C4C.71","type":"string"},"datatype":"string"},"type":"statement","id":"Q40434$F05F1DE6-7B8C-4B47-9E0F-887D7E3CBF4B","rank":"normal"}],"P86":[{"mainsnak":{"snaktype":"value","property":"P86","hash":"a96031634b9f5dafddaf781bbba3adea6bb64ef4","datavalue":{"value":"Conclu\u00eddo","type":"string"},"datatype":"string"},"type":"statement","id":"Q40434$6A1A6A38-D0E9-4946-A26B-2EF482F3096C","rank":"normal"}],"P78":[{"mainsnak":{"snaktype":"value","property":"P78","hash":"5f9b5be68b7400da549761cf15abfdbc4d1e075b","datavalue":{"value":"https://pauloleads.com.br/cases-publicos/","type":"string"},"datatype":"url"},"type":"statement","id":"Q40434$EE666DF8-1EFE-4F7D-BF3E-98E5A8922F44","rank":"normal"}],"P80":[{"mainsnak":{"snaktype":"value","property":"P80","hash":"92b8222fcbb75718504f915073a3f43bd4003d18","datavalue":{"value":{"time":"+2026-08-13T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q40434$E8FA343E-6658-4A67-8E89-8E9710C38F6A","rank":"normal"}],"P89":[{"mainsnak":{"snaktype":"value","property":"P89","hash":"c930115e020a2c04a15ac425c14d2e746f0edfb9","datavalue":{"value":{"entity-type":"item","numeric-id":16017,"id":"Q16017"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q40434$402B2CAF-C762-4524-BCFA-04FD3A3BECA4","rank":"normal"}]},"sitelinks":{}}}}